Latest News and Press Releases

Longeveron to report 2025 full year financial results and provide a business update on March 17, 2026 after the U.S. financial markets close.

JENA, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today...

TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) today announced its fourth quarter (Q4) and full year results for the period ended December 31, 2025, along with an update on...

Pharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

DP World reports strong 2025 financial results globally and across the Americas, driven by resilient trade demand and logistics growth.

Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

BioNTech erwartet ein Jahr mit zahlreichen wertrelevanten Meilensteinen (Katalysatoren) mit sechs Datenveröffentlichungen aus der späten klinischen Entwicklung, welche Immunmodulatoren,...

BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on...

CHICAGO, March 06, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to...

Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‑of‑Phase 2 meeting with the U.S. Food and Drug...